The report ‘Prostate Cancer Screening: The Impact on the NHS’ was published by Prostate Cancer Research at 00:01 UK time on Tuesday 14 October 2025.

It’s responsible for killing 12,000 Brits a year, and this year prostate cancer overtook breast cancer as the most common ...

TUESDAY, Oct. 14, 2025 (HealthDay News) — Former President Joe Biden is now receiving radiation and hormone therapy to treat ...

The Supreme Court has rejected an appeal from conspiracy theorist Alex Jones and left in place the $1.4 billion judgment ...

Clarity Pharmaceuticals (ASX: CU6) (Clarity or Company), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

South Korea's Hyundai ADM Bio said its new cancer drug under development, Penetrium, may prove effective treating diseases ...

Doctors are “overtesting” men for prostate cancer and not targeting “those most likely to benefit,” researchers have warned.Prostate cancer is the most commonly diagnosed cancer in the UK, affecting ...

Meta says teenagers on Instagram will be restricted to seeing PG-13 content by default and won’t be able to change their ...

During his remarks for a dinner event at the American Cornerstone Institute last month, Donald Trump mocked former President ...

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.

Swedish company, which speeds up prostate cancer diagnosis, chooses Milton Park for its first UK laboratory Milton Park has ...